Anticorps Recombinant de lapin anti-CASR

CASR Recombinant Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

243029B11

N° de cat : 86319-1-PBS

Synonymes

Calcium Sensing Receptor, CAR, Extracellular calcium-sensing receptor, FHH, FIH

---

Galerie de données de validation

• 

  WB analysis using 86319-1-RR (same clone as 86319-1-PBS)

  Various lysates were subjected to SDS PAGE followed by western blot with 86319-1-RR (CASR antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 86319-1-PBS in a different storage buffer formulation.

---

Informations sur le produit

86319-1-PBS cible CASR dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain, souris

• Réactivité: Humain, souris
• Hôte / Isotype: Lapin / IgG
• Clonalité: Recombinant
• Type: Anticorps
• Immunogène: Peptide
• Nom complet: calcium-sensing receptor
• Masse moléculaire calculée: 121 kDa
• Poids moléculaire observé: 120 kDa
• Numéro d’acquisition GenBank: NM_000388
• Symbole du gène: Calcium Sensing Receptor
• Identification du gène (NCBI): 846
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par protéine A
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

CASR, also named as GPRC2A, PCAR1, belongs to the G-protein coupled receptor 3 family. Changes in extracellular calcium are thought to modulate a balance between proliferation and differentiation in a variety of cell types. The activity of CASR is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system. It has been shown to play a major role in regulating parathyroid hormone secretion and subsequently influencing the calcium concentration of extracellular fluids. In normal primary keratinocytes and breast epithelial cells, proliferation is inhibited and elevated extracellular calcium levels trigger differentiation. Malignant transformations of these cell types are accompanied by a loss of responsiveness to the anti-proliferative effects of elevated extracellular calcium. Several disorders of calcium homeostasis have been linked to mutations in the CaSR. These include familial hypocalciuric hypercalcemia (FHH), neonatal severe hyperparathyroidism (NSHPT), and autosomal dominant hypocalemia (ADHypo).

{{ptg:RelatedPrimaryAntibodies}}